外科病房患者的血栓预防:临床审计。

IF 2.6 Q2 PERIPHERAL VASCULAR DISEASE
Vascular Health and Risk Management Pub Date : 2023-09-22 eCollection Date: 2023-01-01 DOI:10.2147/VHRM.S418808
Yassin Abdelrahim Abdalla, Arwa Mustafa Kamil, Samya Abbas Abdelrazig Mohamed, Ahmed Hashim Ahmed Mohamed, Eman Khalifa, Mohamed Hamid Abdelsalam Mohamed, Eilaf Eltayeb Abdalla Abdelgadir, Muawiya Dabora, Mohammed Salah Eldin Mohammed Elshikh Awoda
{"title":"外科病房患者的血栓预防:临床审计。","authors":"Yassin Abdelrahim Abdalla,&nbsp;Arwa Mustafa Kamil,&nbsp;Samya Abbas Abdelrazig Mohamed,&nbsp;Ahmed Hashim Ahmed Mohamed,&nbsp;Eman Khalifa,&nbsp;Mohamed Hamid Abdelsalam Mohamed,&nbsp;Eilaf Eltayeb Abdalla Abdelgadir,&nbsp;Muawiya Dabora,&nbsp;Mohammed Salah Eldin Mohammed Elshikh Awoda","doi":"10.2147/VHRM.S418808","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Hospital-acquired thrombosis (HAT) is associated with significant morbidity, mortality, and financial burden globally. Following trusted guidelines for VTE prevention has shown effective, safe, and satisfactory results. This prompts national collaborative efforts to maintain a consensus approach for the safe risk assessment of inpatients and the prescription of thromboprophylaxis.</p><p><strong>Objective: </strong>This study aimed to detect and estimate deviations from international thromboprophylaxis protocols. The study also aimed to raise the quality of practice and adherence to evidence-based protocols in Alshuhada Teaching Hospital.</p><p><strong>Methods: </strong>A cross-sectional audit of general surgical inpatients was performed from October 2021 to May 2022. The first cycle was from 1/10/2021 to 21/10/2021, and the second cycle was from 13/5/2022 to 31/5/2022. The target population was adults aged >18 years. Data were collected via an online checklist on two separate occasions. The criteria were based on the NICE guideline for venous thromboembolism in individuals aged over 16 years: \"Reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism NG89\".</p><p><strong>Results: </strong>Forty-five surgical inpatients were included in this study: 20 in the first cycle and 25 in the second cycle. The first-cycle report showed that only 25% of VTE candidates received this regimen. In the second cycle, practice significantly improved, with 92% of admitted patients having their risk assessment tool completed within 24 h of admission. 79% of VTE prophylaxis candidates were prescribed adequate pharmacological prophylaxis within 14 h of admission.</p><p><strong>Conclusion: </strong>The rate of adequate thromboprophylaxis for inpatients undergoing surgery was very low before clinicians received education on VTE prevention, whereas was evidently high after they had received them. The cause of non-adherence in the pre-intervention phase was a lack of adequate knowledge regarding the magnitude and burden of HAT and the importance of thromboprophylaxis, which has a potential role in preventing the majority of HAT.</p>","PeriodicalId":23597,"journal":{"name":"Vascular Health and Risk Management","volume":"19 ","pages":"651-656"},"PeriodicalIF":2.6000,"publicationDate":"2023-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e4/a6/vhrm-19-651.PMC10521924.pdf","citationCount":"0","resultStr":"{\"title\":\"Thromboprophylaxis in Patients Admitted to the Surgical Ward: Clinical Audit.\",\"authors\":\"Yassin Abdelrahim Abdalla,&nbsp;Arwa Mustafa Kamil,&nbsp;Samya Abbas Abdelrazig Mohamed,&nbsp;Ahmed Hashim Ahmed Mohamed,&nbsp;Eman Khalifa,&nbsp;Mohamed Hamid Abdelsalam Mohamed,&nbsp;Eilaf Eltayeb Abdalla Abdelgadir,&nbsp;Muawiya Dabora,&nbsp;Mohammed Salah Eldin Mohammed Elshikh Awoda\",\"doi\":\"10.2147/VHRM.S418808\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Hospital-acquired thrombosis (HAT) is associated with significant morbidity, mortality, and financial burden globally. Following trusted guidelines for VTE prevention has shown effective, safe, and satisfactory results. This prompts national collaborative efforts to maintain a consensus approach for the safe risk assessment of inpatients and the prescription of thromboprophylaxis.</p><p><strong>Objective: </strong>This study aimed to detect and estimate deviations from international thromboprophylaxis protocols. The study also aimed to raise the quality of practice and adherence to evidence-based protocols in Alshuhada Teaching Hospital.</p><p><strong>Methods: </strong>A cross-sectional audit of general surgical inpatients was performed from October 2021 to May 2022. The first cycle was from 1/10/2021 to 21/10/2021, and the second cycle was from 13/5/2022 to 31/5/2022. The target population was adults aged >18 years. Data were collected via an online checklist on two separate occasions. The criteria were based on the NICE guideline for venous thromboembolism in individuals aged over 16 years: \\\"Reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism NG89\\\".</p><p><strong>Results: </strong>Forty-five surgical inpatients were included in this study: 20 in the first cycle and 25 in the second cycle. The first-cycle report showed that only 25% of VTE candidates received this regimen. In the second cycle, practice significantly improved, with 92% of admitted patients having their risk assessment tool completed within 24 h of admission. 79% of VTE prophylaxis candidates were prescribed adequate pharmacological prophylaxis within 14 h of admission.</p><p><strong>Conclusion: </strong>The rate of adequate thromboprophylaxis for inpatients undergoing surgery was very low before clinicians received education on VTE prevention, whereas was evidently high after they had received them. The cause of non-adherence in the pre-intervention phase was a lack of adequate knowledge regarding the magnitude and burden of HAT and the importance of thromboprophylaxis, which has a potential role in preventing the majority of HAT.</p>\",\"PeriodicalId\":23597,\"journal\":{\"name\":\"Vascular Health and Risk Management\",\"volume\":\"19 \",\"pages\":\"651-656\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2023-09-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e4/a6/vhrm-19-651.PMC10521924.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vascular Health and Risk Management\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2147/VHRM.S418808\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vascular Health and Risk Management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/VHRM.S418808","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

摘要

背景:医院获得性血栓形成(HAT)在全球范围内与严重的发病率、死亡率和经济负担有关。遵循值得信赖的VTE预防指南已显示出有效、安全和令人满意的结果。这促使各国开展合作,为住院患者的安全风险评估和血栓预防处方保持共识。目的:本研究旨在检测和评估与国际血栓预防方案的偏差。该研究还旨在提高Alshuhada教学医院的实践质量和对循证协议的遵守。方法:对2021年10月至2022年5月的普通外科住院患者进行横断面审计。第一个周期为2021年1月10日至2021年10月21日,第二个周期为2022年5月13日至2022年5日31日。目标人群为年龄>18岁的成年人。数据是在两个不同的场合通过在线检查表收集的。该标准基于NICE关于16岁以上患者静脉血栓栓塞的指南:“降低医院获得性深静脉血栓形成或肺栓塞NG89的风险”。结果:本研究包括45名外科住院患者:20名在第一周期,25名在第二周期。第一个周期的报告显示,只有25%的VTE候选人接受了这种方案。在第二个周期中,实践显著改善,92%的入院患者在入院后24小时内完成了风险评估工具。79%的VTE预防候选药物在入院后14小时内得到足够的药物预防。结论:在临床医生接受VTE预防教育之前,接受手术的住院患者的充分血栓预防率非常低,而在他们接受VTE教育之后,充分血栓预防的比率明显较高。干预前阶段不依从性的原因是缺乏对HAT的程度和负担以及血栓预防的重要性的充分了解,血栓预防在预防大多数HAT方面具有潜在作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Thromboprophylaxis in Patients Admitted to the Surgical Ward: Clinical Audit.

Background: Hospital-acquired thrombosis (HAT) is associated with significant morbidity, mortality, and financial burden globally. Following trusted guidelines for VTE prevention has shown effective, safe, and satisfactory results. This prompts national collaborative efforts to maintain a consensus approach for the safe risk assessment of inpatients and the prescription of thromboprophylaxis.

Objective: This study aimed to detect and estimate deviations from international thromboprophylaxis protocols. The study also aimed to raise the quality of practice and adherence to evidence-based protocols in Alshuhada Teaching Hospital.

Methods: A cross-sectional audit of general surgical inpatients was performed from October 2021 to May 2022. The first cycle was from 1/10/2021 to 21/10/2021, and the second cycle was from 13/5/2022 to 31/5/2022. The target population was adults aged >18 years. Data were collected via an online checklist on two separate occasions. The criteria were based on the NICE guideline for venous thromboembolism in individuals aged over 16 years: "Reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism NG89".

Results: Forty-five surgical inpatients were included in this study: 20 in the first cycle and 25 in the second cycle. The first-cycle report showed that only 25% of VTE candidates received this regimen. In the second cycle, practice significantly improved, with 92% of admitted patients having their risk assessment tool completed within 24 h of admission. 79% of VTE prophylaxis candidates were prescribed adequate pharmacological prophylaxis within 14 h of admission.

Conclusion: The rate of adequate thromboprophylaxis for inpatients undergoing surgery was very low before clinicians received education on VTE prevention, whereas was evidently high after they had received them. The cause of non-adherence in the pre-intervention phase was a lack of adequate knowledge regarding the magnitude and burden of HAT and the importance of thromboprophylaxis, which has a potential role in preventing the majority of HAT.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Vascular Health and Risk Management
Vascular Health and Risk Management PERIPHERAL VASCULAR DISEASE-
CiteScore
4.20
自引率
3.40%
发文量
109
审稿时长
16 weeks
期刊介绍: An international, peer-reviewed journal of therapeutics and risk management, focusing on concise rapid reporting of clinical studies on the processes involved in the maintenance of vascular health; the monitoring, prevention, and treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes. In addition, the journal will also seek to define drug usage in terms of ultimate uptake and acceptance by the patient and healthcare professional.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信